Intragastric Balloons Market By Type (Single, Dual, Triple), By Filling Material (Gas Filled, Saline Filled) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.
Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.
The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.
However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.
Segmentation Overview
The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.
Depending on the filling material, the saline filled segment held the highest share in the market in 2023.
According to end users, the hospitals segment accounted for the largest market share in 2023.
Region wise, North America dominated the intragastric balloons market in 2023.
Competitive Scenario
The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.
Key Market Segments
By Type
Single
Dual
Triple
By Filling Material
Gas Filled
Saline Filled
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Obalon Therapeutics
Apollo Endosurgery Inc.
Allurion Technologies Inc.
Spatz Medical
ReShape Lifesciences
Lexel Medical
Endalis
MEDSIL
Silimed Indústria de Implantes Ltda.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Single
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Dual
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Triple
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Filling Material
- 5.2. Gas Filled
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Saline Filled
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Filling Material
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Intragastric Balloons Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Filling Material
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Intragastric Balloons Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Filling Material
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Intragastric Balloons Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Filling Material
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Filling Material
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Intragastric Balloons Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Filling Material
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Intragastric Balloons Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Filling Material
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Intragastric Balloons Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Filling Material
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Intragastric Balloons Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Filling Material
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Intragastric Balloons Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Filling Material
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Intragastric Balloons Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Filling Material
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Filling Material
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Intragastric Balloons Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Filling Material
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Intragastric Balloons Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Filling Material
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Intragastric Balloons Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Filling Material
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Intragastric Balloons Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Filling Material
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Intragastric Balloons Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Filling Material
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Intragastric Balloons Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Filling Material
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Filling Material
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Intragastric Balloons Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Filling Material
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Intragastric Balloons Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Filling Material
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Intragastric Balloons Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Filling Material
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Intragastric Balloons Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Filling Material
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Obalon Therapeutics
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Apollo Endosurgery Inc.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Allurion Technologies Inc.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Spatz Medical
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. ReShape Lifesciences
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Lexel Medical
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Endalis
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. MEDSIL
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Silimed Indústria De Implantes Ltda.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL INTRAGASTRIC BALLOONS MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 2. INTRAGASTRIC BALLOONS MARKET FOR SINGLE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. INTRAGASTRIC BALLOONS MARKET FOR DUAL, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. INTRAGASTRIC BALLOONS MARKET FOR TRIPLE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 5. GLOBAL INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 6. INTRAGASTRIC BALLOONS MARKET FOR GAS FILLED, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. INTRAGASTRIC BALLOONS MARKET FOR SALINE FILLED, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. GLOBAL INTRAGASTRIC BALLOONS MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 9. INTRAGASTRIC BALLOONS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 10. INTRAGASTRIC BALLOONS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 11. INTRAGASTRIC BALLOONS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. INTRAGASTRIC BALLOONS MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 13. NORTH AMERICA INTRAGASTRIC BALLOONS, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 14. NORTH AMERICA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 16. NORTH AMERICA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 17. U.S. INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 18. U.S. INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 19. U.S. INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 20. CANADA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 21. CANADA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 22. CANADA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 23. MEXICO INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 24. MEXICO INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 25. MEXICO INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 26. EUROPE INTRAGASTRIC BALLOONS, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 27. EUROPE INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 29. EUROPE INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 30. FRANCE INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 31. FRANCE INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 32. FRANCE INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 33. GERMANY INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 34. GERMANY INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 35. GERMANY INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 36. ITALY INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 37. ITALY INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 38. ITALY INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 39. SPAIN INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 40. SPAIN INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 41. SPAIN INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 42. UK INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 43. UK INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 44. UK INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 45. REST OF EUROPE INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF EUROPE INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 47. REST OF EUROPE INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 48. ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 49. ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 51. ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 52. CHINA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 53. CHINA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 54. CHINA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 55. JAPAN INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 56. JAPAN INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 57. JAPAN INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 58. INDIA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 59. INDIA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 60. INDIA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 61. SOUTH KOREA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 62. SOUTH KOREA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 63. SOUTH KOREA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 64. AUSTRALIA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 65. AUSTRALIA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 66. AUSTRALIA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 70. LAMEA INTRAGASTRIC BALLOONS, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 71. LAMEA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 73. LAMEA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 74. BRAZIL INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 75. BRAZIL INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 76. BRAZIL INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 77. SOUTH AFRICA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 78. SOUTH AFRICA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 79. SOUTH AFRICA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 80. SAUDI ARABIA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 81. SAUDI ARABIA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 82. SAUDI ARABIA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 83. REST OF LAMEA INTRAGASTRIC BALLOONS, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 84. REST OF LAMEA INTRAGASTRIC BALLOONS, BY FILLING MATERIAL, 2024 - 2033 ($MILLION)
- TABLE 85. REST OF LAMEA INTRAGASTRIC BALLOONS, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 86. OBALON THERAPEUTICS: KEY EXECUTIVES
- TABLE 87. OBALON THERAPEUTICS: COMPANY SNAPSHOT
- TABLE 88. OBALON THERAPEUTICS: OPERATING SEGMENTS
- TABLE 89. OBALON THERAPEUTICS: PRODUCT PORTFOLIO
- TABLE 90. OBALON THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. APOLLO ENDOSURGERY INC.: KEY EXECUTIVES
- TABLE 92. APOLLO ENDOSURGERY INC.: COMPANY SNAPSHOT
- TABLE 93. APOLLO ENDOSURGERY INC.: OPERATING SEGMENTS
- TABLE 94. APOLLO ENDOSURGERY INC.: PRODUCT PORTFOLIO
- TABLE 95. APOLLO ENDOSURGERY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. ALLURION TECHNOLOGIES INC.: KEY EXECUTIVES
- TABLE 97. ALLURION TECHNOLOGIES INC.: COMPANY SNAPSHOT
- TABLE 98. ALLURION TECHNOLOGIES INC.: OPERATING SEGMENTS
- TABLE 99. ALLURION TECHNOLOGIES INC.: PRODUCT PORTFOLIO
- TABLE 100. ALLURION TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. SPATZ MEDICAL: KEY EXECUTIVES
- TABLE 102. SPATZ MEDICAL: COMPANY SNAPSHOT
- TABLE 103. SPATZ MEDICAL: OPERATING SEGMENTS
- TABLE 104. SPATZ MEDICAL: PRODUCT PORTFOLIO
- TABLE 105. SPATZ MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. RESHAPE LIFESCIENCES: KEY EXECUTIVES
- TABLE 107. RESHAPE LIFESCIENCES: COMPANY SNAPSHOT
- TABLE 108. RESHAPE LIFESCIENCES: OPERATING SEGMENTS
- TABLE 109. RESHAPE LIFESCIENCES: PRODUCT PORTFOLIO
- TABLE 110. RESHAPE LIFESCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. LEXEL MEDICAL: KEY EXECUTIVES
- TABLE 112. LEXEL MEDICAL: COMPANY SNAPSHOT
- TABLE 113. LEXEL MEDICAL: OPERATING SEGMENTS
- TABLE 114. LEXEL MEDICAL: PRODUCT PORTFOLIO
- TABLE 115. LEXEL MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. ENDALIS: KEY EXECUTIVES
- TABLE 117. ENDALIS: COMPANY SNAPSHOT
- TABLE 118. ENDALIS: OPERATING SEGMENTS
- TABLE 119. ENDALIS: PRODUCT PORTFOLIO
- TABLE 120. ENDALIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. MEDSIL: KEY EXECUTIVES
- TABLE 122. MEDSIL: COMPANY SNAPSHOT
- TABLE 123. MEDSIL: OPERATING SEGMENTS
- TABLE 124. MEDSIL: PRODUCT PORTFOLIO
- TABLE 125. MEDSIL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. SILIMED INDúSTRIA DE IMPLANTES LTDA.: KEY EXECUTIVES
- TABLE 127. SILIMED INDúSTRIA DE IMPLANTES LTDA.: COMPANY SNAPSHOT
- TABLE 128. SILIMED INDúSTRIA DE IMPLANTES LTDA.: OPERATING SEGMENTS
- TABLE 129. SILIMED INDúSTRIA DE IMPLANTES LTDA.: PRODUCT PORTFOLIO
- TABLE 130. SILIMED INDúSTRIA DE IMPLANTES LTDA.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL INTRAGASTRIC BALLOONS MARKET SEGMENTATION
- FIGURE 2. GLOBAL INTRAGASTRIC BALLOONS MARKET
- FIGURE 3. SEGMENTATION INTRAGASTRIC BALLOONS MARKET
- FIGURE 4. TOP INVESTMENT POCKET IN INTRAGASTRIC BALLOONS MARKET
- FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 8. LOW THREAT OF SUBSTITUTION
- FIGURE 9. HIGH COMPETITIVE RIVALRY
- FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRAGASTRIC BALLOONS MARKET
- FIGURE 11. GLOBAL INTRAGASTRIC BALLOONS MARKET SEGMENTATION, BY TYPE
- FIGURE 12. INTRAGASTRIC BALLOONS MARKET FOR SINGLE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. INTRAGASTRIC BALLOONS MARKET FOR DUAL, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. INTRAGASTRIC BALLOONS MARKET FOR TRIPLE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 15. GLOBAL INTRAGASTRIC BALLOONS MARKET SEGMENTATION, BY FILLING MATERIAL
- FIGURE 16. INTRAGASTRIC BALLOONS MARKET FOR GAS FILLED, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. INTRAGASTRIC BALLOONS MARKET FOR SALINE FILLED, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 18. GLOBAL INTRAGASTRIC BALLOONS MARKET SEGMENTATION, BY END USER
- FIGURE 19. INTRAGASTRIC BALLOONS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 20. INTRAGASTRIC BALLOONS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 21. INTRAGASTRIC BALLOONS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 26. COMPETITIVE DASHBOARD
- FIGURE 27. COMPETITIVE HEATMAP: INTRAGASTRIC BALLOONS MARKET
- FIGURE 28. TOP PLAYER POSITIONING, 2023
- FIGURE 29. OBALON THERAPEUTICS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 30. OBALON THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 31. OBALON THERAPEUTICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 32. APOLLO ENDOSURGERY INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 33. APOLLO ENDOSURGERY INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 34. APOLLO ENDOSURGERY INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 35. ALLURION TECHNOLOGIES INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 36. ALLURION TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 37. ALLURION TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 38. SPATZ MEDICAL: NET SALES, 2021-2023 ($MILLION)
- FIGURE 39. SPATZ MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 40. SPATZ MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 41. RESHAPE LIFESCIENCES: NET SALES, 2021-2023 ($MILLION)
- FIGURE 42. RESHAPE LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 43. RESHAPE LIFESCIENCES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 44. LEXEL MEDICAL: NET SALES, 2021-2023 ($MILLION)
- FIGURE 45. LEXEL MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 46. LEXEL MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 47. ENDALIS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 48. ENDALIS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 49. ENDALIS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 50. MEDSIL: NET SALES, 2021-2023 ($MILLION)
- FIGURE 51. MEDSIL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 52. MEDSIL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 53. SILIMED INDúSTRIA DE IMPLANTES LTDA.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 54. SILIMED INDúSTRIA DE IMPLANTES LTDA.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 55. SILIMED INDúSTRIA DE IMPLANTES LTDA.: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook